2024 EACTS Guidelines on perioperative medication in adult cardiac surgery

Authors/Task Force Members:… - European Journal of …, 2025 - academic.oup.com
The European Association for Cardio-Thoracic Surgery (EACTS) established a
multidisciplinary task force of experts involved in perioperative and long-term care of …

[HTML][HTML] Left atrial appendage occlusion during cardiac surgery to prevent stroke: a systematic review and meta-analysis

A Sayed, A Kamal, I Kamal, AH Fathallah… - The American Journal of …, 2024 - Elsevier
Background Atrial fibrillation accounts for one-sixth of all strokes, potentially leading to
significant disability and death. The left atrial appendage (LAA) is the primary location for …

[HTML][HTML] Evaluating the Relationship Between Gastrointestinal Bleeding and Valvular Heart Disease: A Systematic Review of Clinical Studies

JJ Gries, K Namjouyan, H Ul Hassan Virk… - Gastrointestinal …, 2024 - mdpi.com
Background: Gastrointestinal angiodysplasia is a significant vascular anomaly characterized
by dilated, tortuous blood vessels in the gastrointestinal tract. The current literature …

Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement

AR Fath, A Aglan, O Altaee, H Fichardt… - Clinical …, 2024 - jacc.org
Background The efficacy of direct oral anticoagulants (DOACs) in preventing ischemic and
thromboembolic events may be suboptimal in atrial fibrillation (AF) patients with rheumatic …

[HTML][HTML] Understanding Antithrombotic Agents for Rehabilitation Therapy: A Comprehensive Narrative Review

S Matsumoto, R Ohama, T Hoei, R Tojo, T Nakamura - Cureus, 2024 - ncbi.nlm.nih.gov
In rehabilitation medicine, attention must be paid to the medication. Among them,
antithrombotic drugs are used for the initial treatment and secondary prevention of stroke, so …

[HTML][HTML] 心房颤动患者服用利伐沙班致出血的研究进展

姚娟 - Advances in Clinical Medicine, 2023 - hanspub.org
心房颤动是较常见的一种心律失常, 目前新型口服抗凝药(NOACs) 已逐渐取代华法林,
成为房颤患者的首选治疗药物, 其中利伐沙班的使用比较普遍, 但临床上使用利伐沙班时 …

Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the ENBALV Trial

C Izumi, M Amano, S Fukushima, H Yaku… - … Drugs and Therapy, 2024 - Springer
Abstract Background and Purpose Anticoagulant therapy with vitamin K antagonists is
recommended within 3 to 6 months after bioprosthetic valve replacement to prevent …

Atrial Fibrillation and Bioprosthetic Valves: An Evidence-Based Approach to Anticoagulation Therapy With Direct Oral Anticoagulants and Vitamin K Antagonists: A …

M Orban - The American Journal of Cardiology, 2023 - search.proquest.com
One of the principal questions with which cardiovascular clinical research has been
challenged over the last decade is finding the ideal antithrombotic strategy in patients with …